Caxton Associates (New York)’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-26,788
Closed -$379K 653
2021
Q1
$379K Buy
+26,788
New +$369K 0.03% 218

Other funds holding DBD

Caxton Associates (New York)'s DBD Position: Q2 2021 in Review

Caxton Associates (New York) sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2021, closing a stake of 26,788 shares — an estimated $379K sold.

Caxton Associates (New York) first reported a position in DBD in Q1 2021 and held it in 1 quarter. The position peaked at $379K in Q1 2021. 182 funds tracked by Wall St. Rank hold DBD as of Q2 2021.

  • Caxton Associates (New York) reported no remaining Diebold Nixdorf Incorporated position as of Q2 2021 after selling out during the quarter.
  • Caxton Associates (New York) sold 26,788 Diebold Nixdorf Incorporated shares in Q2 2021, an estimated $379K.
  • Caxton Associates (New York) first reported a position in Diebold Nixdorf Incorporated in Q1 2021 and held it in 1 quarter.
  • Caxton Associates (New York)'s Diebold Nixdorf Incorporated position peaked at $379K in Q1 2021.
  • 182 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2021.

Based on Caxton Associates (New York)'s 13F filing for Q2 2021, filed 16 Aug 2021.